Is 3OZ0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3OZ0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 3OZ0's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 3OZ0's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3OZ0?
Key metric: As 3OZ0 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 3OZ0. This is calculated by dividing 3OZ0's market cap by their current
revenue.
What is 3OZ0's PS Ratio?
PS Ratio
30.5x
Sales
CA$11.47m
Market Cap
CA$367.40m
3OZ0 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 3OZ0 is expensive based on its Price-To-Sales Ratio (30.5x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is 3OZ0's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
3OZ0 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
30.5x
Fair PS Ratio
10.3x
Price-To-Sales vs Fair Ratio: 3OZ0 is expensive based on its Price-To-Sales Ratio (30.5x) compared to the estimated Fair Price-To-Sales Ratio (10.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 3OZ0 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€1.65
€4.16
+152.1%
21.1%
€5.50
€3.26
n/a
6
Nov ’25
€1.56
€4.37
+180.2%
22.4%
€5.49
€3.14
n/a
5
Oct ’25
€1.80
€4.32
+139.9%
24.9%
€6.00
€3.00
n/a
6
Sep ’25
€1.78
€4.43
+149.1%
22.6%
€6.01
€3.00
n/a
6
Aug ’25
€1.71
€4.77
+179.1%
16.3%
€6.01
€3.67
n/a
6
Jul ’25
€1.61
€5.16
+220.3%
22.3%
€7.50
€4.09
n/a
6
Jun ’25
€1.74
€5.03
+189.3%
22.6%
€7.42
€4.05
n/a
6
May ’25
€1.99
€4.85
+143.7%
27.0%
€7.52
€3.01
n/a
7
Apr ’25
€2.02
€5.00
+147.6%
23.5%
€7.49
€3.81
n/a
7
Mar ’25
€1.73
€5.60
+223.5%
25.5%
€7.57
€3.85
n/a
7
Feb ’25
€2.24
€5.60
+149.9%
25.5%
€7.57
€3.85
n/a
7
Jan ’25
€2.50
€6.05
+142.2%
17.5%
€7.53
€4.11
n/a
7
Dec ’24
€2.50
€5.95
+137.9%
18.6%
€7.53
€4.11
n/a
6
Nov ’24
€2.84
€5.95
+109.4%
18.6%
€7.53
€4.11
€1.56
6
Oct ’24
€2.80
€7.45
+166.1%
40.5%
€13.70
€4.11
€1.80
6
Sep ’24
€2.88
€7.55
+162.1%
38.0%
€13.55
€4.74
€1.78
6
Aug ’24
€3.76
€7.88
+109.6%
34.6%
€13.74
€5.49
€1.71
6
Jul ’24
€4.02
€7.72
+92.1%
31.6%
€13.46
€5.72
€1.61
7
Jun ’24
€4.20
€7.72
+83.9%
31.6%
€13.46
€5.72
€1.74
7
May ’24
€4.76
€7.72
+62.3%
31.6%
€13.46
€5.72
€1.99
7
Apr ’24
€4.36
€7.92
+81.7%
35.7%
€13.88
€5.90
€2.02
6
Mar ’24
€4.00
€8.39
+109.8%
35.3%
€13.99
€5.94
€1.73
5
Feb ’24
€5.40
€8.21
+52.1%
32.4%
€13.78
€5.86
€2.24
6
Jan ’24
€3.98
€9.21
+131.4%
30.1%
€14.33
€5.91
€2.50
5
Dec ’23
€4.48
€9.21
+105.6%
30.1%
€14.33
€5.91
€2.50
5
Nov ’23
€4.12
€9.71
+135.8%
27.9%
€14.80
€6.11
€2.84
6
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.